News
CI
354.51
+0.63%
2.23
Cigna's Evernorth to Offer Humira Biosimilar Without Out-of-Pocket Fee
Cigna-owned Evernorth Health Services says it will provide a Humira biosimilar with no out-of-pocket fees starting in June. The company says the biosimilar price would be about 85% lower than the Humira list price. Humira is used as a treatment for rheumatoid arthritis, Crohn's disease.
Dow Jones · 11h ago
CIGNA GROUP SAYS EVERNORTH ANNOUNCES HUMIRA BIOSIMILAR AVAILABLE AT $0 OUT OF POCKET FOR ACCREDO PATIENTS IN JUNE
Reuters · 11h ago
CIGNA SAYS BIOSIMILAR TO ABBVIE'S HUMIRA WILL BE AVAILABLE THROUGH AGREEMENTS WITH MULTIPLE MANUFACTURERS
Reuters · 11h ago
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
Evernorth Health Services will have a Humira biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy Accredo beginning this June. The biosimilar price will be about 85% lower than the list price for Humira®. The program is estimated to save individual patients around $3,500 on average per year. High- and low-concentration interchangeable biosimilar will be available.
PR Newswire · 11h ago
EVERNORTH HEALTH SERVICES - HIGH- AND LOW-CONCENTRATION INTERCHANGEABLE BIOSIMILAR WILL BE PRODUCED FOR QUALLENT PHARMACEUTICALS
Reuters · 11h ago
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Cigna to offer close copies of AbbVie's arthritis drug Humira with $0 copay at specialty pharmacy beginning in June. The company will stock biosimilar versions of the drug at its Accredo pharmacy in the U.S. Cigna says the move should save eligible patients $3,500 per year. Abbvie has held onto 98% of the Humira market.
Reuters · 11h ago
Daily Dividend Report: PFE, SCHW, CI, MPC, AVY
NASDAQ · 14h ago
Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapies
Walgreens Boots Alliance expands specialty pharmacy with unit dedicated to cell and gene therapies. Walgreens expects to be largest provider of specialty pharmacy services with $24B in annual revenue. The company's focus on gene and cell therapies comes months after first gene-editing therapy was approved.
Seeking Alpha · 18h ago
Stay Ahead With 4 Healthcare Stocks Poised for Q1 Earnings Beat
NASDAQ · 18h ago
AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries
AM Best has affirmed the Financial Strength Rating of A and the Long-Term Issuer Credit Ratings of The Cigna Group (Cigna) The ratings reflect the strong operating performance and favorable business profile of the company. The ratings also reflect the group's balance sheet strength.
Barchart · 21h ago
Cigna declares $1.40 dividend
Dividend Stocks News Cigna declares $1.40 dividend Apr. 25, 2024. Forward yield 1.59% Payable June 20; for shareholders of record June 4. The company has now announced a dividend of $ 1.40 for two consecutive quarters.
Seeking Alpha · 1d ago
CIGNA GROUP - DECLARED A CASH DIVIDEND OF $1.40 PER SHARE OF ITS COMMON STOCK
Reuters · 1d ago
Press Release: The Cigna Group Declares Quarterly Dividend
The Cigna Group Declares Quarterly Dividend of $1.40 per share of its common stock. The dividend is payable on June 20, 2024 to shareholders of record on June 4, 2024. The company is a global health company committed to creating a better future.
Dow Jones · 1d ago
The Cigna Group Declares Quarterly Dividend
The Cigna Group declares a cash dividend of $1.40 per share of its common stock. The dividend is payable on June 20, 2024 to shareholders of record on June 4, 2024. The group is a global health company committed to creating a better future.
PR Newswire · 1d ago
Artisan Global Equity Fund Q1 2024 Commentary
Seeking Alpha · 1d ago
FTC looking to accelerate inquiry into prescription-drug middlemen, chair says
MarketWatch · 2d ago
THE CIGNA GROUP ANNOUNCES APPEARANCE AT THE BOFA SECURITIES 2024 HEALTH CARE CONFERENCE
Reuters · 2d ago
The Cigna Group Announces Appearance at the BofA Securities 2024 Health Care Conference
Brian Evanko, executive vice president and chief financial officer, will present at the BofA Securities 2024 Health Care Conference on May 15, 2024, in Las Vegas, NV. The Cigna Group's presentation is expected to begin at approximately 11:40 a.m. ET. A live webcast of the presentation will be available at the cigna group's website.
PR Newswire · 2d ago
3 Best Blue-Chip Stocks to Buy in April 2024, According to Analysts
TipRanks · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-AZZ, Vanda Pharma, Matterport
U.S. Stocks rose on Monday in choppy trading. The Dow Jones Industrial Average was up 1.01% at 38,371.51. The top three S&P 500 percentage gainers were Ford Motor Co, Nvidia and Vanda Pharma. The market is looking ahead to major tech earnings and a key inflation print this week. AZZ, Vanda Pharmaceutical and Matterport are up on the day.
Reuters · 3d ago
More
Webull provides a variety of real-time CI stock news. You can receive the latest news about Cigna Group through multiple platforms. This information may help you make smarter investment decisions.
About CI
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.